Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia

@article{Nagai2012ProlactinCD,
  title={Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia},
  author={G. Nagai and K. Mihara and A. Nakamura and T. Suzuki and K. Nemoto and S. Kagawa and I. Ohta and Hajime Arakaki and T. Kondo},
  journal={Psychiatry and Clinical Neurosciences},
  year={2012},
  volume={66}
}
The authors investigated the correlation between prolactin concentrations during aripiprazole treatment and various factors, including age, sex, plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, and genetic polymorphisms of dopamine D2 receptor (DRD2) and cytochrome P450(CYP)2D6. 
Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis
...
1
2
...

References

SHOWING 1-10 OF 35 REFERENCES
Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele
Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
...
1
2
3
4
...